Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemangiosarcoma × Immunoglobulin G × Clear all

Sponsor

Conditions

Ovarian Neoplasms 14 Fallopian Tube Neoplasms 14 Glioblastoma 7 Carcinoma, Renal Cell 7 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 6 Brenner Tumor 6 Squamous Cell Carcinoma of Head and Neck 5 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Melanoma 4 Gliosarcoma 4 Breast Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Recurrent Squamous Cell Lung Carcinoma 3 Oligodendroglioma 3 Urinary Bladder Neoplasms 2 Spinal Cord Neoplasms 2 Medulloblastoma 2 Glioma 2 Colonic Neoplasms 2 Carcinoma 2 Astrocytoma 2 Adenocarcinoma of Lung 2 Vipoma 1 Uveal Melanoma 1 Uterine Neoplasms 1 Urethral Neoplasms 1

Interventions

pazopanib 5 Doxorubicin 3 carotuximab 2 Sorafenib 2 Radiotherapy, Conformal 2 Gemcitabine 2 tremelimumab 1 trebananib 1 temsirolimus 1 romidepsin 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 cixutumumab 1 Watchful Waiting 1 TTI-621 1 Sunitinib 1 Sirolimus 1 Razoxane 1 Paclitaxel 1 Observation 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 HhAntag691 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Dexrazoxane 1 Cyproheptadine 1 Bevacizumab 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡